Denti Paolo, Sala Alessandra, Belluschi Igor, Alfieri Ottavio
Department of Cardiovascular and Thoracic Surgery, San Raffaele University Hospital, Milan, Italy.
Ann Cardiothorac Surg. 2021 Jan;10(1):15-27. doi: 10.21037/acs-2020-mv-18.
Patients with severe symptomatic mitral regurgitation, if left untreated, have a poor prognosis. In those patients not eligible for mitral valve (MV) surgery, percutaneous repair may improve clinical outcomes. In the past 15 years several devices have been developed to address different MV lesions. This manuscript will review the advancement of transcatheter MV repair through the years, focusing on technologies for which consistent clinical data is available.
重度症状性二尖瓣反流患者若不接受治疗,预后较差。对于那些不符合二尖瓣(MV)手术条件的患者,经皮修复可能改善临床结局。在过去15年里,已研发出多种器械来处理不同的MV病变。本文将回顾多年来经导管MV修复的进展,重点关注有一致临床数据的技术。